history
Search in
1 ingredient found
Sort by:
Relevance

Details

  • SegmentPersonal care
  • INCI nameFucus vesiculosus, Undaria pinnatifida
  • Sustainability claimsNatural
  • FunctionActive ingredients
  • ApplicationsCapsules, Creams, Gels & jellies, Lotions, Pellets
  • Chemical groupBiological polymers, Carbohydrates
  • Chemical propertiesHydrophilic
  • OriginFucus Vesiculosus, Undaria Pinnatifida

Ingredient Description

DISCRETE FUCOIDANS FOR ADVANCED APPLICATIONS Marinova has the expertise and capability to develop and produce high purity fucoidan fractions for a wide range of advanced applications. Marinova is experienced in creating novel compounds for very specific purposes, from biomaterials research through to medical devices and pharmaceutical development. Our capabilities extend to the manufacture of depyrogenated fucoidan fractions with defined molecular weight profiles and varying degrees of sulfation and acetylation. Cation profiles can also be modified if required. By altering these structural properties, it is possible to isolate distinct fucoidan compounds with enhanced efficacy and superior compatibility with other biomaterials and therapeutic agents. Marinova is at the forefront of developing discrete fucoidans for medical research. Our scientists understand the unique physicochemical properties of fucoidan and how these may be tailored to influence uptake and achieve targeted therapeutic effects. We conduct an extensive characterisation of all our fucoidan fractions to ensure their suitability for both in vitro and in vivo assays and we guarantee reproducibility. We also provide our clients with an assurance that commercial quantities are manufactured under certified GMP and – if necessary – in compliance with relevant European and US pharmaceutical requirements.

CompanyLogo

  • Company nameMarinova
  • Legal nameMarinova Pty, Ltd.
  • HeadquartersCambridge, Australia
  • Number of employees11-50
  • DescriptionMarinova is a progressive biotechnology company focussed on the research, development and manufacture of high purity fucoidan compounds. Founded in 2003 and now established as the leader in its field, Marinova is recognised globally for the quality and efficacy of its fucoidan products. We are also renowned for our commitment to innovation in all facets of our business, from sustainable harvesting practices and advanced manufacturing technologies through to the research, development and validation of our products. Our aqueous Maritech® extraction process generates high purity fucoidan compounds without the use of harsh chemicals, solvents or high temperatures. The result: a portfolio of highly characterised, nature-identical fucoidan ingredients with superior bioactivity.
  • WebsiteCompany website